Bioptimus Secures $35 Million Seed Funding to Pioneer AI in Biology

The Paris-based startup, founded by ex-Googlers and Owkin scientists, aims to revolutionize biomedical research with its AI model.

Bioptimus, a Paris-based AI startup, raises $35 million in seed funding to develop a foundational AI model focused exclusively on biology.
The startup aims to leverage AI to improve disease diagnosis, precision medicine, and create new biomolecules for medical or environmental use.
Bioptimus is founded by ex-Googlers and Owkin scientists, intending to build the first universal biology AI model.
The company faces unique data challenges, dealing with sensitive clinical data not publicly available, contrasting with models trained on web-crawled data.
Bioptimus plans to use multimodal patient data from Owkin and AWS compute for its AI model development.